Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.16m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Net Asset Value(s)

13 Jan 2012 16:04

RNS Number : 5641V
Maven Income & Growth VCT PLC
13 January 2012
Β 

ο»Ώ

Interim Management Statement

Β 

Maven Income and Growth VCT PLC (the Company) - quarter ended 30 November 2011

Β 

This Interim Management Statement, for the quarter ended 30 November 2011, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 December 2011 to the date of this announcement. This statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

Β 

1.

Financial highlights

Β 

Β·; Net Asset Value (NAV)1 of 65.1p per share at 30 November 2011, compared to 63.6p per share at 31 August 2011;

Β·; NAV total return2 of 107.7p per share at 30 November 2011, compared to 106.2p per share at 31 August 2011;

Β·; 229,000 Ordinary Shares bought back for cancellation during the quarter; and

Β·; Interim dividend of 1.5p per share in respect of the year ending 29 February 2012, paid on 9 December 2011.

Β 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 30 November 2011. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 31 August 2011, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

Β 

2.

Investments and disposals

Β 

During the quarter ended 30 November 2011, a total of Β£708,000 was invested in six unlisted companies. Aggregate proceeds of Β£252,000 were received from the disposal of holdings in one AIM quoted and five unlisted holdings, against a total cost of Β£103,000.

Β 

3.

Recent developments

Β 

Between 1 December 2011 and the date of this Statement, investments totalling Β£626,000 were made in two unlisted companies; Β£850,000 was invested in UK government securities; Β£37,000 was received from the partial redemption of loan stock at par by an unlisted company; and the sale of an AIM quoted holding generated proceeds of Β£11,000 against cost of Β£15,000.

Β 

4.

Offer for Subscription

Β 

On 7 December 2011 the Company announced the launch of an Offer of New Ordinary Shares. The Offer will close on 5 April 2012 in respect of the 2011/12 tax year and on 27 April 2012 in respect of the 2012/13 tax year.

Β 

Other than as described above and any changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 September 2011 to 30 November 2011, or in the period from 1 December 2011 to the date of this announcement, which would have had a material impact on the financial position of the Company.

Β 

Issued on behalf of the Board

Β 

Maven Capital Partners UK LLP

Secretary

Β 

13 January 2012

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
NAVGGUWUGUPPGQW
Date   Source Headline
4th Jun 20214:16 pmRNSAnnual Financial Report
4th May 20213:37 pmRNSIssue of Equity
20th Apr 20214:56 pmRNSTransaction in Own Shares
16th Apr 20214:40 pmRNSNet Asset Value and Proposed Final Dividend
6th Apr 202112:50 pmRNSDirector/PDMR Shareholding
6th Apr 20217:00 amRNSIssue of Equity
24th Mar 20215:56 pmRNSStatement re Offer for Subscription
23rd Mar 20213:41 pmRNSPublication of Suppl.Prospcts
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSIssue of Equity
8th Feb 20219:56 amRNSStatement re Offer for Subscription
4th Feb 20215:10 pmRNSTransaction in Own Shares
29th Jan 20214:42 pmRNSTransaction in Own Shares
28th Jan 20214:40 pmRNSStatement re Offer for Subscription
22nd Jan 20213:13 pmRNSNet Asset Value(s)
27th Nov 202010:41 amRNSResult of General Meeting
20th Nov 20205:18 pmRNSIssue of Equity
16th Nov 20204:53 pmRNSTransaction in Own Shares
13th Nov 20203:43 pmRNSStatement re Dividend Investment Scheme
26th Oct 20207:00 amRNSPublication of a Prospectus
19th Oct 20204:43 pmRNSHalf-year Report
15th Oct 20204:45 pmRNSStatement re NAV and Interim Dividend
26th Aug 20205:19 pmRNSTransaction in Own Shares
29th Jul 20204:42 pmRNSTransaction in Own Shares
28th Jul 20204:48 pmRNSTransaction in Own Shares
22nd Jul 20203:12 pmRNSNet Asset Value(s)
22nd Jul 20202:25 pmRNSStatement re Intended Joint Offersfor Subscription
22nd Jul 202012:18 pmRNSResult of AGM
29th May 202011:37 amRNSAnnual Financial Report
26th May 20204:54 pmRNSTransaction in Own Shares
27th Apr 20204:19 pmRNSTransaction in Own Shares
21st Apr 20205:17 pmRNSNet Asset Value & Final Dividend
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSSuspension of Dividend Investment Scheme
19th Mar 20201:48 pmRNSDirector Declaration
23rd Jan 20203:36 pmRNSNet Asset Value(s)
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
28th Nov 20195:06 pmRNSTransaction in Own Shares
22nd Nov 20193:31 pmRNSDirector/PDMR Shareholding
22nd Nov 20192:45 pmRNSIssue of Equity
20th Nov 20194:44 pmRNSStatement re Dividend Investment Scheme
31st Oct 20194:42 pmRNSHalf-year Report
15th Oct 20192:33 pmRNSTransaction in Own Shares
15th Oct 20199:56 amRNSStatement re Net Asset Value and Interim Dividend
31st Jul 20193:37 pmRNSTransaction in Own Shares
4th Jul 20191:08 pmRNSNet Asset Value(s)
4th Jul 201912:55 pmRNSResult of AGM
24th May 20193:09 pmRNSAnnual Financial Report
20th May 20194:34 pmRNSTransaction in Own Shares
20th May 201911:29 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.